On our Social Channels

From our News Center

S.I.F.I- Società Industria Farmaceutica Italiana S.p.A. (“SIFI”), and Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company,...
 

 

28 July

Heidelberg Clinical Center (Germany), first of four selected trial centers, started the clinical activities related  to the International Interventional Clinical Study...
Follow Us!